Emmaus Life Sciences, Inc. (EMMA)

OTCMKTS · Delayed Price · Currency is USD

0.0120

+0.0005 (4.35%)

Aug 11, 2026, 11:26 AM EST

Emmaus Life Sciences Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	12.03	12.45	16.65	29.6	18.39	20.61
Revenue Growth	-27.33%	-25.22%	-43.73%	60.94%	-10.77%	-11.04%
Gross Profit	11.23	11.6	15.45	28.26	15.8	17.3
Operating Income	0.39	0.23	-1.89	3.54	-6.59	-6.13
Net Income	-8.5	-7.49	-6.45	-3.73	-10.63	-15.95
Earnings Per Share	-0.13	-0.12	-0.10	-0.07	-0.21	-0.32
EPS Growth	-	-	-	-	-	-

Revenue by Geography

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
United States	8.37	9.05	13.48	22
International	3.57	3.18	2.67	6.96
Other	0.1	0.23	0.51	0.64
Total	12.03	12.45	16.65	29.6

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	1.07	2.13	1.39	2.55	2.02	2.28
Total Debt	31.96	32.56	32.96	33.42	30.82	22.41
Net Cash (Debt)	-30.89	-30.43	-31.57	-30.88	-28.8	-20.13
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-0.47	-0.48	-0.50	-0.58	-0.58	-0.41

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	-0.63	-0.01	-2.29	-1.5	-5.07	-1.25
Capital Expenditures	-0	-0	-0.01	-0.02	-0.03	-0.07
Free Cash Flow	-0.64	-0.01	-2.3	-1.52	-5.1	-1.33
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	93.35%	93.12%	92.79%	95.47%	85.93%	83.93%
Operating Margin	3.23%	1.85%	-11.37%	11.96%	-35.81%	-29.73%
Pretax Margin	-70.56%	-60.09%	-38.58%	-12.81%	-57.45%	-77.25%
Profit Margin	-70.64%	-60.16%	-38.75%	-12.61%	-57.78%	-77.37%
FCF Margin	-5.28%	-0.10%	-13.80%	-5.14%	-27.73%	-6.44%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 11, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Forward PE	-	5.50	5.50	5.50	4.34	-
PS Ratio	0.07	0.07	0.03	0.21	0.70	4.00